Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Rasko, John E J  [Clear All Filters]
2024
Chu GJ, Bailey CG, Nagarajah R, Liang O, Metierre C, Sagnella SM, Castelletti L, Yeo D, Adelstein S, Rasko JEJ. Mesothelin antigen density influences anti-mesothelin chimeric antigen receptor T cell cytotoxicity. Cytotherapy. 2024.
Dhungel BP, Winburn I, Pereira Cda Fonseca, Huang K, Chhabra A, Rasko JEJ. Understanding AAV vector immunogenicity: from particle to patient. Theranostics. 2024;14(3):1260-1288.
2023
Chu GJ, Bailey CG, Nagarajah R, Sagnella SM, Adelstein S, Rasko JEJ. The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation. Cancer Cell Int. 2023;23(1):327.
Rasko JEJ, Power C. The deadly legacy of a stem cell charlatan. BMJ. 2023;381:p1367.
Vila-Farré M, Rozanski A, Ivanković M, Cleland J, Brand JN, Thalen F, Grohme MA, von Kannen S, Grosbusch AL, Vu HT-K, et al. Evolutionary dynamics of whole-body regeneration across planarian flatworms. Nat Ecol Evol. 2023.
Chu GJ, Linton A, Kao S, Klebe S, Adelstein S, Yeo D, Rasko JEJ, Cooper WA. High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma. Histopathology. 2023.
Ikonomou L, Cuende N, Forte M, Grilley BJ, Levine AD, Munsie M, Rasko JEJ, Turner L, Bidkhori HR, Ciccocioppo R, et al. International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products. Cytotherapy. 2023;25(9):920-929.
Vega R, Antila M, Perez C, Mookadam M, Xie F, Zhang W, Rizwan A, Yao Z, Rasko JEJ. SARS-CoV-2-neutralising antibody BGB-DXP593 in mild-to-moderate COVID-19: a multicentre, randomised, double-blind, phase 2 trial. EClinicalMedicine. 2023;57:101832.
Wong ACH, Wong JJ-L, Rasko JEJ, Schmitz U. SpliceWiz: interactive analysis and visualization of alternative splicing in R. Brief Bioinform. 2023;25(1).
2022
Tabar MSharifi, Francis H, Yeo D, Bailey CG, Rasko JEJ. Mapping oncogenic protein interactions for precision medicine. Int J Cancer. 2022.
Dorney R, Dhungel BP, Rasko JEJ, Hebbard L, Schmitz U. Recent advances in cancer fusion transcript detection. Brief Bioinform. 2022.
Zhao G, Pan AY, Feng Y, Rasko JEJ, Bailey CG, Lovicu FJ. Sprouty and Spred temporally regulate ERK1/2-signaling to suppress TGFβ-induced lens EMT. Exp Eye Res. 2022:109070.
Shah JS, Milevskiy MJG, Petrova V, Au AYM, Wong JJL, Visvader JE, Schmitz U, Rasko JEJ. Towards resolution of the intron retention paradox in breast cancer. Breast Cancer Res. 2022;24(1):100.
2021
George LA, Monahan PE, M Eyster E, Sullivan SK, Ragni MV, Croteau SE, Rasko JEJ, Recht M, Samelson-Jones BJ, MacDougall A, et al. Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A. N Engl J Med. 2021;385(21):1961-1973.
2020
George LA, Ragni MV, Rasko JEJ, Raffini LJ, Samelson-Jones BJ, Ozelo M, Hazbon M, Runowski AR, Wellman JA, Wachtel K, et al. Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B. Mol Ther. 2020.
2018
Susanto A, Zhao G, Wazin F, Feng Y, Rasko JEJ, Bailey CG, Lovicu FJ. Spred negatively regulates lens growth by modulating epithelial cell proliferation and fiber differentiation. Exp Eye Res. 2018.
2016
Berger I, Ahmad A, Bansal A, Kapoor T, Sipp D, Rasko JEJ. Global Distribution of Businesses Marketing Stem Cell-Based Interventions. Cell Stem Cell. 2016;19(2):158-62.
2014
Clancy JL, Patel HR, Hussein SMI, Tonge PD, Cloonan N, Corso AJ, Li M, Lee D-S, Shin J-Y, Wong JJL, et al. Small RNA changes en route to distinct cellular states of induced pluripotency. Nat Commun. 2014;5:5522.